Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000057

Chief Scientific Officer sold 421,000 shares at an average $0.12 ($50,933)

From the SEC's structured data for this filing

Trades in this filing

NIGALAYE ASHOK G · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2013-11-11 Sale : show line 1 in the form −39,000 $0.12 $4,778 21,535,048 I
2013-11-26 Sale : show line 2 in the form −357,000 $0.12 $43,126 21,428,528 I
2013-11-27 Sale : show line 3 in the form −25,000 $0.12 $3,030 21,421,048 I
Open-market sales · 421,000 sh · avg $0.12 · $50,933
Loading xslF345X03/primary_doc.xml…